Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. Amanda Sealy, CNN CNN

...

FDA, Ellume recalling more than 2 million at-home COVID-19 test kits Australian manufacturer Ellume is recalling about 2 million at-home COVID-19 test kits over concerns about "higher than acceptable" false positives. Nathaniel Weixel TheHill

Australian manufacturer Ellume is recalling about 2 million at-home COVID-19 test kits over concerns about "higher than acceptable" false positives.

Shift Covid testing from draconian punishment to empowerment - STAT Instead of viewing Covid-19 testing as a means of limiting access, reframe it as an empowering tool to let people gather more confidently. Maaisha Osman STAT

Public health is at its best when it is pragmatic in the face of complex problems fraught with stigma and uncertainty, like moving in the direction of full vaccination in the face of many Americans’ entrenched or even defiant anti-vaccination sentiment.

India's COVID Spike and Plummet. What Have We Learned? Experts discuss the country's second deadly wave Shannon Firth medpagetoday

The severity of India's second COVID-19 wave took the world by surprise. Cases skyrocketed, at one point accounting for roughly half of the total infections reported globally. Then, almost as quickly, the numbers plunged.